|
EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel
Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026
08-Dec-2025 / 14:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 –
interim assumption of the Chairmanship of the Supervisory Board by Peter Kameritsch |
Jena, 8 December 2025
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) and Maximilian Foerst have mutually agreed to terminate Maximilian Foerst’s Executive Board mandate as of 31 December 2025.
The reason for this decision is a violation, acknowledged by Maximilian Foerst, of the ZEISS Group’s internal Code of Conduct in connection with a conflict of interest involving interactions with an individual within the ZEISS internal working environment, which dates back several years. The case is not related to the business activities of ZEISS Group or to the business of Carl Zeiss Meditec AG.
The Supervisory Board is working at full speed to identify a successor. On an interim basis, Andreas Pecher, currently Chairman of the Supervisory Board of Carl Zeiss Meditec AG and CEO of Carl Zeiss AG, will assume the role of CEO of Carl Zeiss Meditec AG as of 1 January 2026. He will resign from his Supervisory Board mandate beforehand. The Supervisory Board will be chaired on an interim basis by Peter Kameritsch.
Accordingly, as of 1 January 2026, the Executive Board of Carl Zeiss Meditec AG will consist of Andreas Pecher (Chief Executive Officer, ad interim) and Justus Felix Wehmer (Chief Financial Officer).
The successfully initiated strategic realignment under Maximilian Foerst will continue at an unchanged pace.
|
| |
Contact for investors and press
Sebastian Frericks
Head of Group Finance & Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: investors.med@zeiss.com
End of Inside Information
08-Dec-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
|
| Language: |
English |
| Company: |
Carl Zeiss Meditec AG |
|
Göschwitzer Str. 51-52 |
|
07745 Jena, Germany |
|
Germany |
| Phone: |
+49 (0)3641 220-0 |
| Fax: |
+49 (0)3641 220-112 |
| E-mail: |
investors.meditec@zeiss.com |
| Internet: |
www.zeiss.de/meditec-ag/ir |
| ISIN: |
DE0005313704 |
| WKN: |
531370 |
| Indices: |
MDAX, TecDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
2241862 |
| |
| End of Announcement |
EQS News Service |
2241862 08-Dec-2025 CET/CEST
EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel
Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026
08-Dec-2025 / 14:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 –
interim assumption of the Chairmanship of the Supervisory Board by Peter Kameritsch |
Jena, 8 December 2025
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) and Maximilian Foerst have mutually agreed to terminate Maximilian Foerst’s Executive Board mandate as of 31 December 2025.
The reason for this decision is a violation, acknowledged by Maximilian Foerst, of the ZEISS Group’s internal Code of Conduct in connection with a conflict of interest involving interactions with an individual within the ZEISS internal working environment, which dates back several years. The case is not related to the business activities of ZEISS Group or to the business of Carl Zeiss Meditec AG.
The Supervisory Board is working at full speed to identify a successor. On an interim basis, Andreas Pecher, currently Chairman of the Supervisory Board of Carl Zeiss Meditec AG and CEO of Carl Zeiss AG, will assume the role of CEO of Carl Zeiss Meditec AG as of 1 January 2026. He will resign from his Supervisory Board mandate beforehand. The Supervisory Board will be chaired on an interim basis by Peter Kameritsch.
Accordingly, as of 1 January 2026, the Executive Board of Carl Zeiss Meditec AG will consist of Andreas Pecher (Chief Executive Officer, ad interim) and Justus Felix Wehmer (Chief Financial Officer).
The successfully initiated strategic realignment under Maximilian Foerst will continue at an unchanged pace.
|
| |
Contact for investors and press
Sebastian Frericks
Head of Group Finance & Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: investors.med@zeiss.com
End of Inside Information
08-Dec-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
|
| Language: |
English |
| Company: |
Carl Zeiss Meditec AG |
| Göschwitzer Str. 51-52 |
| 07745 Jena, Germany |
| Germany |
| Phone: |
+49 (0)3641 220-0 |
| Fax: |
+49 (0)3641 220-112 |
| E-mail: |
investors.meditec@zeiss.com |
| Internet: |
www.zeiss.de/meditec-ag/ir |
| ISIN: |
DE0005313704 |
| WKN: |
531370 |
| Indices: |
MDAX, TecDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
2241862 |
| |
| End of Announcement |
EQS News Service |
2241862 08-Dec-2025 CET/CEST
![\"\"](\"https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2241862&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6\")
|